Illumina countersues Qiagen in patent fight; Sleep apnea device field could surpass $19B by 2017;

 @FierceMedDev: Philips Healthcare grows solidly during Q2. More | Follow @FierceMedDev

 @MarkHFierce: In a novel twist for NIH funding, a $65M grant is designed to boost translational device/Dx research. Item | Follow @MarkHFierce

 @DamianFierce: Navidea is moving forward in the Alzheimer's imaging race, vying with GE Healthcare and Eli Lilly. Story | Follow @DamianFierce

> San Diego diagnostics company Illumina ($ILMN) is countersuing Intelligent Bio-Systems and Qiagen (which recently acquired IBS) for infringement of three Illumina DNA-sequencing patents. Columbia University and IBS initially sued Illumina for patent infringement on March 26. Release

> Aurora Imaging Technology inked an exclusive China distribution deal with Sumec Group, drastically boosting Aurora's reach in the Chinese market for its breast MRI technology. Release

> BG Medicine has filed a 510(k) application for a new test designed to measure the blood level of galectin-3, a protein that plays a role in worsening heart failure. Release

> Bollington, a U.K. insurance broker, will expand into the medical devices sector. Story

> Life Technologies ($LIFE) has developed a same-day molecular diagnostic for E. coli, and the company is working with the USDA to implement the test. More

> Some market analysts predict the global sleep apnea device field to be worth $19.7 billion by 2017. Story

> Phoenix's InnerSpace Neuro has launched a new tunneled ventricular catheter, designed to treat traumatic brain injury. Item

Biotech News

 @FierceBiotech: PTC investors back lead orphan drug with $30M round. More | Follow @FierceBiotech

 @JohnCFierce: PR folks in Texas taking exception with my remark about CPRIT controversies in cell medica piece. Just the one, they say. (ha, ha, ha) | Follow @JohnCFierce

 @RyanMFierce: Venter and Stanford built first complete software model of organism, a simple bacterium. Simulated humans someday? More | Follow @RyanMFierce

> Biotech execs get creative as venture cash flow dwindles. More

> Cell Medica lands $26.5M in venture cash to fuel U.S. expansion. News

Pharma News

 @FiercePharma: Indian companies often plant moles to spy on competitors and hire hackers to dig into IT systems, survey finds. More | Follow @FiercePharma

> J&J appeals $1.2B Risperdal marketing fine. More

> Onyx staffs up for Kyprolis' assault on myeloma market. Story

> Afinitor's breast cancer OK could add $1.5B to Novartis sales. News

CRO News

> DSM expands CMO biz with first Brazilian deal. Story

> Indian PM urged to tax CMOs in excise-free zones. Article

> Parexel partners to develop drugs in S. Korea. News

> CoreRx triples capacity with Florida plant. Item

> Covance selling off animal testing lab. Article

Biotech IT News

> 10 Reasons Why Biotech Needs Big Data. Special Report

> Pfizer builds credentials as 'data company'. More

> Medidata CEO seeks organic growth over big eClinical buyouts. Item

> WorldOne takes over Sermo social network for docs. News

> NCI spotlights cancer gene-drug matchmaker software. Story

> Venter, Stanford build first computer model of complete organism. Article

Suggested Articles

The immunoassay will measure neurofilament light chain protein levels, found in the blood and cerebrospinal fluid, and linked to nerve damage.

Emmecell aims to make corneal transplant surgery, which can take up to a year to heal from and fails up to 20% of the time, a relic of the past.

Seven developers will provide digital health solutions aimed at the COVID-19 pandemic, including smartphone apps, wearables and big data programs.